{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:42:25Z","timestamp":1791988945359,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ventricular tachycardia (VT) is a potentially life-threatening arrhythmia, that can lead to sudden cardiac death. While conventional treatments include antiarrhythmic drugs, catheter ablation, and ICD implantation, recent studies suggest that stereotactic body radiotherapy (SBRT) offers a non-invasive alternative for the treatment of VT. The objective of this systematic review is to summarize the current evidence on SBRT for refractory VT from a radiotherapeutic and technical perspective and to assess its safety and effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>he systematic search was conducted according to the PRISMA guidelines, using the four databases PubMed, Cochrane, Scopus, and Web of Science. After screening, 15 publications were included and analyzed in this review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 15 studies were identified in the literature, describing 173 patients. SBRT was delivered as a single fraction using standard LINAC- or CyberKnife-devices with varying isodose prescriptions, motion management, and imaging guidance, highlighting the need for standardized protocols. SBRT consistently reduced VT burden across these studies, with reduction rates ranging from 50 to 99%, and improved quality of life in some patients. However, VT recurrences have also been described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Delivery of SBRT for VT is similar to that for malignant diseases but requires specialized imaging and mapping procedures to ensure precise delivery of radiation to small ectopic areas within the beating heart. SBRT seems safe and effective in reducing VT in first clinical trials, though it is not yet a routine treatment. Further controlled trials with standardized treatments and endpoints are needed for confirmation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>This study does not involve a clinical trial; therefore, a clinical trial number is not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-025-02704-w","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T05:50:42Z","timestamp":1756446642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Technical aspects of SBRT for therapy-refractory ventricular tachycardia: a systematic review for radiation oncologists"],"prefix":"10.1186","volume":"20","author":[{"given":"Alicia","family":"Greiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Grajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"R\u00f6mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Pietschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Wurschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"2704_CR1","unstructured":"Foth C, Gangwani MK, Ahmed I, Alvey H. Ventricular tachycardia. StatPearls. Treasure Island (FL). Volume 30. StatPearls Publishing; 2023."},{"key":"2704_CR2","doi-asserted-by":"publisher","first-page":"100760","DOI":"10.1016\/j.ijcha.2021.100760","volume":"34","author":"M Martinek","year":"2021","unstructured":"Martinek M, Manninger M, Sch\u00f6nbauer R, Scherr D, Schukro C, P\u00fcrerfellner H, et al. Expert consensus on acute management of ventricular arrhythmias - VT network Austria. Int J Cardiol Heart Vasc. 2021;34:100760. https:\/\/doi.org\/10.1016\/j.ijcha.2021.100760.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"1079","key":"2704_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/postgradmedj-2015-133550","volume":"91","author":"KL Looi","year":"2015","unstructured":"Looi KL, Tang A, Agarwal S. Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator. Postgrad Med J. 2015;91(1079):519\u201326. https:\/\/doi.org\/10.1136\/postgradmedj-2015-133550.","journal-title":"Postgrad Med J"},{"issue":"3","key":"2704_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10840-020-00848-1","volume":"61","author":"G Liu","year":"2021","unstructured":"Liu G, Xu X, Yi Q, Lv T. The efficacy of catheter ablation versus ICD for prevention of ventricular tachycardia in patients with ischemic heart disease: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2021;61(3):435\u201343. https:\/\/doi.org\/10.1007\/s10840-020-00848-1.","journal-title":"J Interv Card Electrophysiol"},{"issue":"11","key":"2704_CR5","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1111\/jce.15259","volume":"32","author":"C Wei","year":"2021","unstructured":"Wei C, Qian PC, Boeck M, Bredfeldt JS, Blankstein R, Tedrow UB, et al. Cardiac stereotactic body radiation therapy for ventricular tachycardia: current experience and technical gaps. J Cardiovasc Electrophysiol. 2021;32(11):2901\u201314. https:\/\/doi.org\/10.1111\/jce.15259.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2704_CR6","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, et al. Stereotactic body radiation therapy: the report of AAPM task group 101. Med Phys. 2010;37:4078\u2013101. https:\/\/doi.org\/10.1118\/1.3438081.","journal-title":"Med Phys"},{"issue":"1","key":"2704_CR7","doi-asserted-by":"publisher","first-page":"euae305","DOI":"10.1093\/europace\/euae305","volume":"27","author":"A Gupta","year":"2024","unstructured":"Gupta A, Sattar Z, Chaaban N, Ranka S, Carlson C, Sami F, et al. Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review. Europace. 2024;27(1):euae305. https:\/\/doi.org\/10.1093\/europace\/euae305.","journal-title":"Europace"},{"issue":"1","key":"2704_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.hrthm.2024.07.029","volume":"22","author":"M Miszczyk","year":"2025","unstructured":"Miszczyk M, Hoeksema WF, Kuna K, Blamek S, Cuculich PS, Grehn M, et al. Stereotactic arrhythmia radioablation (STAR)-A systematic review and meta-analysis of prospective trials on behalf of the stopstorm.eu consortium. Heart Rhythm. 2025;22(1):80\u20139. https:\/\/doi.org\/10.1016\/j.hrthm.2024.07.029.","journal-title":"Heart Rhythm"},{"key":"2704_CR9","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71. Published 2021 Mar 29.","journal-title":"BMJ"},{"key":"2704_CR10","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"2704_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10840-022-01352-4","volume":"66","author":"D Aras","year":"2023","unstructured":"Aras D, \u00c7etin EH\u00d6, Ozturk HF, Ozdemir E, Kara M, Ekizler FA, et al. Stereotactic body radioablation therapy as an immediate and early term antiarrhythmic palliative therapeutic choice in patients with refractory ventricular tachycardia. J Interv Card Electrophysiol. 2023;66(1):135\u201343. https:\/\/doi.org\/10.1007\/s10840-022-01352-4.","journal-title":"J Interv Card Electrophysiol"},{"issue":"4","key":"2704_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jacep.2023.12.002","volume":"10","author":"J Ha\u0161kov\u00e1","year":"2024","unstructured":"Ha\u0161kov\u00e1 J, Wichterle D, Kautzner J, \u0160ramko M, Peichl P, Knybel PEng L, et al. Efficacy and safety of stereotactic radiotherapy in patients with recurrent ventricular tachycardias: the Czech experience. JACC Clin Electrophysiol. 2024;10(4):654\u201366. https:\/\/doi.org\/10.1016\/j.jacep.2023.12.002.","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"2704_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1253\/circrep.CR-23-0003","volume":"5","author":"M Amino","year":"2023","unstructured":"Amino M, Kabuki S, Kunieda E, Hashimoto J, Sugawara A, Sakai T, et al. Interim report of a Japanese phase II trial for cardiac stereotactic body radiotherapy in refractory ventricular Tachycardia - Focus on target determination. Circ Rep. 2023;5(3):69\u201379. https:\/\/doi.org\/10.1253\/circrep.CR-23-0003. Published 2023 Feb 9.","journal-title":"Circ Rep"},{"key":"2704_CR14","doi-asserted-by":"publisher","unstructured":"Lloyd MS, Wight J, Schneider F, Hoskins M, Attia T, Escott C Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients. Heart Rhythm et al. 2020;17(3):415\u2013422. https:\/\/doi.org\/10.1016\/j.hrthm.2019.09.028","DOI":"10.1016\/j.hrthm.2019.09.028"},{"key":"2704_CR15","doi-asserted-by":"crossref","unstructured":"Miszczyk M, Sajdok M, Bednarek J, Latusek T, Wojakowski W, Tomasik B et al. Stereotactic management of arrhythmia- radiosurgery in treatment of ventricular tachycardia (SMART-VT). Results of a prospective safety trial. Radiother Oncol. 2023;188.","DOI":"10.1016\/j.radonc.2023.109857"},{"issue":"7","key":"2704_CR16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/europace\/euz133","volume":"21","author":"R Neuwirth","year":"2019","unstructured":"Neuwirth R, Cvek J, Knybel L, Jiravsky O, Molenda L, Kodaj M, et al. Stereotactic radiosurgery for ablation of ventricular tachycardia. Europace. 2019;21(7):1088\u201395. https:\/\/doi.org\/10.1093\/europace\/euz133.","journal-title":"Europace"},{"issue":"2","key":"2704_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10840-021-01060-5","volume":"62","author":"C Carbucicchio","year":"2021","unstructured":"Carbucicchio C, Andreini D, Piperno G, Catto V, Conte E, Cattani F, et al. Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase ib\/ii study. J Interventional Cardiac Electrophysiol. 2021;62(2):427\u201339. https:\/\/doi.org\/10.1007\/s10840-021-01060-5.","journal-title":"J Interventional Cardiac Electrophysiol"},{"issue":"7","key":"2704_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00066-023-02091-9","volume":"199","author":"D Krug","year":"2023","unstructured":"Krug D, Zaman A, Eidinger L, Grehn M, Boda-Heggemann J, Rudic B, et al. Radiosurgery for ventricular tachycardia (RAVENTA): interim analysis of a multicenter multiplatform feasibility trial. Strahlenther Onkol. 2023;199(7):621\u201330. https:\/\/doi.org\/10.1007\/s00066-023-02091-9.","journal-title":"Strahlenther Onkol"},{"issue":"8","key":"2704_CR19","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.hrthm.2020.02.036","volume":"17","author":"C Gianni","year":"2020","unstructured":"Gianni C, Rivera D, Burkhardt JD, Pollard B, Gardner E, Maguire P, et al. Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia. Heart Rhythm. 2020;17(8):1241\u20138. https:\/\/doi.org\/10.1016\/j.hrthm.2020.02.036.","journal-title":"Heart Rhythm"},{"issue":"2","key":"2704_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.hroo.2022.11.006","volume":"4","author":"WI Chang","year":"2023","unstructured":"Chang WI, Jo HH, Cha MJ, Chang JH, Choi CH, Kim HJ, et al. Short-term and long-term effects of noninvasive cardiac radioablation for ventricular tachycardia: A single-center case series. Heart Rhythm O2. 2023;4(2):119\u201326. https:\/\/doi.org\/10.1016\/j.hroo.2022.11.006.","journal-title":"Heart Rhythm O2"},{"issue":"3","key":"2704_CR21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/europace\/euad020","volume":"25","author":"MH van der Ree","year":"2023","unstructured":"van der Ree MH, Dieleman EMT, Visser J, Planken RN, Boekholdt SM, de Bruin-Bon RHA, et al. Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial. Europace. 2023;25(3):1015\u201324. https:\/\/doi.org\/10.1093\/europace\/euad020.","journal-title":"Europace"},{"key":"2704_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.hrthm.2023.10.005","volume":"21","author":"J Arkles","year":"2024","unstructured":"Arkles J, Markman T, Trevillian R, Yegya-Raman N, Garg L, Nazarian S, et al. One-year outcomes after stereotactic body radiotherapy for refractory ventricular tachycardia. Heart Rhythm. 2024;21:18\u201324. https:\/\/doi.org\/10.1016\/j.hrthm.2023.10.005.","journal-title":"Heart Rhythm"},{"issue":"3","key":"2704_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10840-020-00849-0","volume":"61","author":"R Chin","year":"2021","unstructured":"Chin R, Hayase J, Hu P, Cao M, Deng J, Ajijola O, et al. Non-invasive stereotactic body radiation therapy for refractory ventricular arrhythmias: an institutional experience. J Interventional Cardiac Electrophysiol. 2021;61(3):535\u201343. https:\/\/doi.org\/10.1007\/s10840-020-00849-0.","journal-title":"J Interventional Cardiac Electrophysiol"},{"key":"2704_CR24","doi-asserted-by":"publisher","first-page":"C248","DOI":"10.1093\/eurheartj\/suac016","volume":"24","author":"G Molon","year":"2022","unstructured":"Molon G, Giaj-Levra N, Costa A, Bonapace S, Cuccia F, Marinelli A, et al. Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia. Eur Heart J Supplement. 2022;24:C248\u201353. https:\/\/doi.org\/10.1093\/eurheartj\/suac016.","journal-title":"Eur Heart J Supplement"},{"issue":"3","key":"2704_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/CIRCULATIONAHA.118.038261","volume":"139","author":"CG Robinson","year":"2019","unstructured":"Robinson CG, Samson PP, Moore KMS, Hugo GD, Knutson N, Mutic S, et al. Phase I\/II trial of Electrophysiology-Guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation. 2019;139(3):313\u201321. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038261.","journal-title":"Circulation"},{"issue":"24","key":"2704_CR26","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1056\/NEJMoa1613773","volume":"377","author":"PS Cuculich","year":"2017","unstructured":"Cuculich PS, Schill MR, Kashani R, Mutic S, Lang A, Cooper D, Faddis M, Gleva M, Noheria A, Smith TW, Hallahan D, Rudy Y, Robinson CG. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med. 2017;377(24):2325\u201336. https:\/\/doi.org\/10.1056\/NEJMoa1613773.","journal-title":"N Engl J Med"},{"issue":"9","key":"2704_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/pace.14512","volume":"45","author":"C Wei","year":"2022","unstructured":"Wei C, Boeck M, Qian PC, Vivenzio T, Elizee Z, Bredfeldt JS, et al. Cost of cardiac stereotactic body radioablation therapy versus catheter ablation for treatment of ventricular tachycardia. Pacing Clin Electrophysiol. 2022;45(9):1124\u201331. https:\/\/doi.org\/10.1111\/pace.14512.","journal-title":"Pacing Clin Electrophysiol"},{"key":"2704_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jacep.2022.09.002","volume":"9","author":"SA Virk","year":"2023","unstructured":"Virk SA, Kumar S. Catheter ablation of ventricular tachycardia in patients with structural heart disease: a meta-analysis. JACC Clin Electrophysiol. 2023;9:255\u20137. https:\/\/doi.org\/10.1016\/j.jacep.2022.09.002.","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"2704_CR29","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tcm.2023.12.008","volume":"34","author":"K Benali","year":"2024","unstructured":"Benali K, Zei PC, Lloyd M, Kautzner J, Guenancia C, Ninni S, et al. One-year mortality and causes of death after stereotactic radiation therapy for refractory ventricular arrhythmias: A systematic review and pooled analysis. Trends Cardiovasc Med. 2024;34(7):488\u201396. https:\/\/doi.org\/10.1016\/j.tcm.2023.12.008.","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"2704_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00066-015-0817-3","volume":"191","author":"B Gauter-Fleckenstein","year":"2015","unstructured":"Gauter-Fleckenstein B, Israel CW, Dorenkamp M, Dunst J, Roser M, Schimpf R, et al. DEGRO\/DGK guideline for radiotherapy in patients with cardiac implantable electronic devices. Strahlenther Onkol. 2015;191(5):393\u2013404. https:\/\/doi.org\/10.1007\/s00066-015-0817-3.","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"2704_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00066-024-02345-0","volume":"201","author":"J Warmbrunn","year":"2025","unstructured":"Warmbrunn J, Straube C, Haase HU, Sinnecker D, Laugwitz KL, Combs SE, et al. Influence of radiotherapy on cardiac implantable devices and leads-a single-institution analysis and critical evaluation of current guidelines. Strahlenther Onkol. 2025;201(4):463\u201371. https:\/\/doi.org\/10.1007\/s00066-024-02345-0.","journal-title":"Strahlenther Onkol"},{"issue":"12","key":"2704_CR32","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s00066-019-01502-0","volume":"195","author":"F Steger","year":"2019","unstructured":"Steger F, Hautmann MG, S\u00fc\u00df C, Hubauer U, \u00dccer E, Maier L, et al. Radiotherapy of patients with cardiac implantable electronic devices according to the DEGRO\/DGK guideline-is the risk of relevant errors overestimated? Radiotherapie von patienten Mit kardialen implantierbaren elektronischen ger\u00e4ten entsprechend der DEGRO\/DGK-Leitlinie\u2013 wird Das Risiko f\u00fcr relevante fehlfunktionen \u00fcbersch\u00e4tzt? Strahlenther Onkol. 2019;195(12):1086\u201393. https:\/\/doi.org\/10.1007\/s00066-019-01502-0.","journal-title":"Strahlenther Onkol"},{"issue":"23","key":"2704_CR33","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1016\/j.jacc.2017.10.030","volume":"70","author":"SR Dukkipati","year":"2017","unstructured":"Dukkipati SR, Koruth JS, Choudry S, Miller MA, Whang W, Reddy VY. Catheter ablation of ventricular tachycardia in structural heart disease: indications, strategies, and Outcomes-Part II. J Am Coll Cardiol. 2017;70(23):2924\u201341. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.030.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2704_CR34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10585-021-10122-x","volume":"38","author":"F Cuccia","year":"2021","unstructured":"Cuccia F, Mazzola R, Pastorello E, Figlia V, Giaj-Levra N, Nicosia L, et al. SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity. Clin Exp Metastasis. 2021;38(5):475\u201381. https:\/\/doi.org\/10.1007\/s10585-021-10122-x.","journal-title":"Clin Exp Metastasis"},{"issue":"11","key":"2704_CR35","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.6061\/clinics\/2012(11)04","volume":"67","author":"C Szlejf","year":"2012","unstructured":"Szlejf C, Farfel JM, Curiati JA, Couto Ede B Jr, Jacob-Filho W, Azevedo RS. Medical adverse events in elderly hospitalized patients: a prospective study. Clin (Sao Paulo). 2012;67(11):1247\u201352. https:\/\/doi.org\/10.6061\/clinics\/2012(11)04.","journal-title":"Clin (Sao Paulo)"},{"issue":"7","key":"2704_CR36","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.hrthm.2024.02.037","volume":"21","author":"K Kancharla","year":"2024","unstructured":"Kancharla K, Olson A, Salavatian S, Kuwabara Y, Martynyuk Y, Dutta P, et al. Ventricular arrhythmia inducibility in Porcine infarct model after stereotactic body radiation therapy. Heart Rhythm. 2024;21(7):1154\u201360. https:\/\/doi.org\/10.1016\/j.hrthm.2024.02.037.","journal-title":"Heart Rhythm"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02704-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02704-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02704-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:20:29Z","timestamp":1781608829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-025-02704-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02704-w","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent and approval of ethics committee were waived due to the nature of this analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Human ethics and consent to participate are not applicable due to the nature of this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}